Improved ATM Kinase Inhibitor KU-60019 Radiosensitizes Glioma Cells, Compromises Insulin, AKT and ERK Prosurvival Signaling, and Inhibits Migration and Invasion

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0519